MabVax Therapeutics (OTCMKTS:MBVX) operating in the cancer diagnostic and immunotherapy genre, will showcase their business model and progress at the 2015 Biotech Showcase. Why are analyst so optimistic about MBVX? Their corporate update will include updates on its HuMab 5B1 diagnostic product and therapeutic…